300813
vs
S
Shanghai Composite
300813
Over the past 12 months, ZheJiangTailin Bioengineering Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +54% compared to the Shanghai Composite's +25% growth.
Stocks Performance
300813 vs Shanghai Composite
Performance Gap
300813 vs Shanghai Composite
Performance By Year
300813 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ZheJiangTailin Bioengineering Co Ltd
Glance View
Zhejiang Tailin Bioengineering Co., Ltd. engages in the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products, as well as organic substance analysis instruments. The company is headquartered in Hangzhou, Zhejiang and currently employs 869 full-time employees. The company went IPO on 2020-01-14. The firm's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The firm distributes its products within domestic market and to overseas markets.
